iCAD, Inc. ICAD
Set alert
3.87 0.00 0.00%
At close · Jul 17
3.87 Day range 3.87
1.18 52-week range 2.65
- YTD
- +111.48%
- 1 year
- +182.48%
- Open
- 3.87
- Prev close
- 3.87
- Mkt cap
- 44.41M
- Vol
- 190.13K
- Avg vol
- 252.54K
- EPS
- -0.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.87
- High
- 3.87
- Forward P/E
- -8.02
- Beta
- 1.48
- Short ratio
- 1.51
- Inst. own
- 27.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.80
- 200-d avg
- 1.58
- 1y target
- 4.38
5Y chart
Events in this range
- Sep 1, 2022Rating: JMP Securities · — → Market Outperform
- Mar 29, 2023Rating: Lake Street · — → Buy
- Mar 29, 2023Rating: BTIG · — → Buy
- Apr 4, 2023Rating: Oppenheimer · — → Outperform
- Apr 13, 2023Rating: JMP Securities · — → Outperform
- Jul 19, 2023Rating: Lake Street · Buy → Buy
- Aug 14, 2023Earnings: -0.07; estimate 0; surprise —%
- Nov 13, 2023Earnings: -0.04; estimate 0; surprise —%
- Mar 12, 2024Earnings: -0.02; estimate 0; surprise —%
- May 14, 2024Earnings: -0.05; estimate 0; surprise —%
- Aug 13, 2024Earnings: -0.07; estimate 0; surprise —%
- Nov 13, 2024Earnings: -0.07; estimate 0; surprise —%
Signals (66)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| SMA: Bullish | Apr 17, 2025 | 1 year ago |
| SMA: Bullish | Apr 17, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| RSI: Overbought | Jan 30, 2025 | 1 year ago |
| SMA: Bullish | Jan 8, 2025 | 1 year ago |
| SMA: Bearish | Dec 17, 2024 | 1 year ago |
| SMA: Bullish | Dec 10, 2024 | 1 year ago |
| SMA: Bearish | Nov 19, 2024 | 1 year ago |
| RSI: Overbought | Nov 12, 2024 | 1 year ago |
| SMA: Bullish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | May 17, 2024 | 2 years ago |
| SMA: Bullish | May 17, 2024 | 2 years ago |
| SMA: Bearish | Apr 19, 2024 | 2 years ago |
| SMA: Bearish | Apr 19, 2024 | 2 years ago |
| SMA: Bullish | Apr 12, 2024 | 2 years ago |
| SMA: Bearish | Mar 14, 2024 | 2 years ago |
| SMA: Bullish | Feb 29, 2024 | 2 years ago |
| SMA: Bullish | Feb 29, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 29, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 18, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 4, 2024 | 2 years ago |
| SMA: Bullish | Dec 21, 2023 | 2 years ago |
| SMA: Bearish | Dec 14, 2023 | 2 years ago |
| SMA: Bullish | Dec 7, 2023 | 2 years ago |
| SMA: Bearish | Oct 17, 2023 | 3 years ago |
| SMA: Bullish | Sep 26, 2023 | 3 years ago |
| SMA: Bearish | Sep 19, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 19, 2023 | 3 years ago |
| SMA: Bearish | Aug 22, 2023 | 3 years ago |
| RSI: Overbought | Jul 18, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 27, 2023 | 3 years ago |
| MACD: Buy Signal | May 30, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 28, 2023 | 3 years ago |
| SMA: Bearish | Mar 14, 2023 | 3 years ago |
| SMA: Bearish | Mar 14, 2023 | 3 years ago |
| SMA: Bullish | Feb 21, 2023 | 3 years ago |
| SMA: Bullish | Feb 21, 2023 | 3 years ago |
| SMA: Bearish | Feb 14, 2023 | 3 years ago |
| SMA: Bullish | Jan 3, 2023 | 3 years ago |
| SMA: Bearish | Nov 22, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 15, 2022 | 3 years ago |
| MACD: Sell Signal | Sep 19, 2022 | 4 years ago |
| RSI: Oversold | Sep 19, 2022 | 4 years ago |
| RSI: Oversold | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Jul 25, 2022 | 4 years ago |
| RSI: Oversold | Jun 17, 2022 | 4 years ago |
| SMA: Bullish | May 27, 2022 | 4 years ago |
Key statistics
- Market cap
- 44.41M
- Enterprise value
- 27.16M
- Trailing P/E
- 0.00
- Forward P/E
- -8.02
- PEG ratio
- 0.00
- Price / sales
- 2.36
- Price / book
- 1.33
- EPS (TTM)
- -0.20
- Beta
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -12.13%
- Revenue (TTM)
- 18.80M
- Revenue growth
- 20.60%
- Free cash flow
- -2.94M
- Total cash
- 20.35M
- Total debt
- 469.00K
- Return on equity
- -14.86%
- Shares outstanding
- 26.35M
- Short % of float
- 0.96%
- 50-day average
- 1.80
- 200-day average
- 1.58
Analyst view
Consensus: none
Price target (mean) 4.38 +13.0% upside
Now 3.87
- Target (low)
- 2.50
- Target (mean)
- 4.38
- Target (high)
- 9.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.06.
Financials — quick view
ICAD Revenue — quarterly 4.87M
ICAD Net income — quarterly -833.00K
ICAD EPS — quarterly -0.03
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.07 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.07 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -0.05 | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.00 | -0.02 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.04 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.07 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 19, 2023 | Lake Street | main | Buy | Buy |
| Apr 13, 2023 | JMP Securities | main | — | Outperform |
| Apr 4, 2023 | Oppenheimer | main | — | Outperform |
| Mar 29, 2023 | BTIG | main | — | Buy |
| Mar 29, 2023 | Lake Street | main | — | Buy |
| Sep 1, 2022 | JMP Securities | main | — | Market Outperform |
About iCAD, Inc.
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- icadmed.com
News
- ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD
- iCAD Reports Financial Results for First Quarter Ended March 31, 2025
- ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD
- $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc. - ICAD
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
- ICAD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iCad, Inc. Is Fair to Shareholders
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
Your note
Sign in to keep a note on ICAD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN DANA R | Chief Executive Officer | Purchase | Mar 30, 2023 | 40,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.27% | 1,132,658 | 1.91M | Sep 29, 2024 |
| First Eagle Investment Management, LLC | 2.54% | 675,161 | 1.14M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.27% | 601,290 | 1.01M | Sep 29, 2024 |
| Blackrock Inc. | 1.32% | 351,617 | 592.47K | Sep 29, 2024 |
| AMH Equity Ltd. | 1.12% | 296,052 | 498.85K | Sep 29, 2024 |
| Greenwood Capital Associates, Inc. | 1.11% | 295,147 | 497.32K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.91% | 771,983 | 1.30M | Sep 29, 2024 |
| First Eagle Small Opportunity Fund | 2.40% | 637,491 | 1.07M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.20% | 319,228 | 537.90K | Sep 29, 2024 |
| General American Investors Co | 0.76% | 200,434 | 337.73K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.54% | 143,159 | 241.22K | Oct 30, 2024 |
| Perritt Microcap Opportunities Fund | 0.45% | 119,000 | 200.51K | Sep 29, 2024 |